| Effects of Exposure to 0.06 ppm Ozone on FEV1 in Humans: A Secondary Analysis of Existing Data James S. Brown,1 Thomas F. Bateson,2 and William F. McDonnell3 1National Center for Environmental Assessment, U.S. Environmental Protection Agency, Research Triangle Park, North Carolina, USA; 2National Center for Environmental Assessment, U.S. Environmental Protection Agency, Washington, DC, USA; 3William F. McDonnell Consulting, Chapel Hill, North Carolina, USA Abstract Background: Ozone is a potent photochemical oxidant that produces transient, reversible decrements in the lung function of acutely exposed individuals. A recent study provided previously unavailable clinical data for 30 healthy young adults exposed to O3 at 0.06 ppm. That study showed significant effects of 0.08 ppm on lung function, confirming the findings of others. However, exposure to 0.06 ppm O3 was not reported to significantly affect lung function. Objectives: We conducted this analysis to reevaluate the existing lung function data of the volunteers previously exposed to 0.06 ppm O3. Methods: We obtained pre- and postexposure data on forced expiratory volume in 1 sec (FEV1) for all subjects who were previously exposed for 6.6 hr to filtered air or to 0.06 ppm or 0.08 ppm O3. We used standard statistical methods appropriate for paired comparisons to reanalyze FEV1 responses after exposure to 0.06 ppm O3 relative to filtered air. Results: Controlling for filtered air responses, 24 of the 30 subjects experienced an O3-induced decrement in FEV1. On average, 0.06 ppm O3 exposure caused a 2.85% reduction in FEV1 (p < 0.002) , which was consistent with the predicted FEV1 response from existing models. Although the average response was small, two subjects had > 10% FEV1 decrements. Conclusions: Exposure to 0.06 ppm O3 causes a biologically small but highly statistically significant decrease in mean FEV1 responses of young healthy adults. Key words: air pollutants, photochemical oxidants, spirometry. Environ Health Perspect 116:1023–1026 (2008) . doi:10.1289/ehp.11396 available via http://dx.doi.org/ [Online 21 April 2008] Address correspondence to J.S. Brown, U.S. Environmental Protection Agency, Office of Research and Development, National Center for Environmental Assessment, B243-01, Research Triangle Park, NC 27711 USA. Telephone: (919) 541-0765. Fax: (919) 541-1818. E-mail: Brown.James@epa.gov W.F.M. was funded by U.S. EPA contract EP07H001352. This document has been reviewed in accordance with U.S. Environmental Protection Agency (EPA) policy and approved for publication. Mention of trade names or commercial products does not constitute endorsement or recommendation for use. The views expressed in this article are those of the authors and do not necessarily reflect the views or policies of the U.S. EPA. Unrelated to the production of this article, W.F.M. received funding from the American Petroleum Institute to evaluate new ozone health effects data and to conduct research related to a human ozone exposure–response model. The other authors declare they have no competing financial interests. Received 20 February 2008 ; accepted 21 April 2008. The full version of this article is available for free in HTML or PDF formats. |